Cargando…
Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose
BACKGROUND: The aim of this report was to assess the efficacy and safety of a combination of vitamin E, an antioxidant, and Eve Primrose in the management of painful diabetes mellitus (DM) neuropathy. MATERIALS AND METHODS: This was an interventional study that evaluated the efficacy and safety of a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192992/ https://www.ncbi.nlm.nih.gov/pubmed/25364681 http://dx.doi.org/10.4103/2230-8210.140270 |
_version_ | 1782338886995804160 |
---|---|
author | Ogbera, Anthonia Okeoghene Ezeobi, Emmanuel Unachukwu, Chioma Oshinaike, Olajumoke |
author_facet | Ogbera, Anthonia Okeoghene Ezeobi, Emmanuel Unachukwu, Chioma Oshinaike, Olajumoke |
author_sort | Ogbera, Anthonia Okeoghene |
collection | PubMed |
description | BACKGROUND: The aim of this report was to assess the efficacy and safety of a combination of vitamin E, an antioxidant, and Eve Primrose in the management of painful diabetes mellitus (DM) neuropathy. MATERIALS AND METHODS: This was an interventional study that evaluated the efficacy and safety of a combination of vitamin E and Eve Primrose in the management of DM neuropathy. The study was conducted at the Diabetic Centre of the Lagos State University Teaching Hospital, Ikeja. Eighty individuals with type 2 DM who had painful neuropathy were recruited for this study, which took place for a duration of 1 year. The study subjects underwent clinical and biochemical assessment at baseline and were given vitamin E in a dose of 400 mg in combination with Eve Primrose in doses ranging 500-1000 mg/day. They were afterward assessed for relief of symptoms and possible untoward effects after 2 weeks and, thereafter, monthly for 3 months. The main outcome measure was amelioration of symptoms of neuropathy. RESULTS: The mean age and age range of the study subjects were 58.2 years and 37-70 years, respectively. A total of 70 patients (88%) of the study population reported relief from neuropathic pains. Clinical parameters were comparable between the responders and non-responders. One characteristic feature of the non-responders was that they all had vibration perception threshold of ≥25 mV, which was indicative of severe neuropathy. CONCLUSION: The combination of vitamin E and Eve Primrose is beneficial in the management of mild to moderate diabetic neuropathy. |
format | Online Article Text |
id | pubmed-4192992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-41929922014-11-01 Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose Ogbera, Anthonia Okeoghene Ezeobi, Emmanuel Unachukwu, Chioma Oshinaike, Olajumoke Indian J Endocrinol Metab Original Article BACKGROUND: The aim of this report was to assess the efficacy and safety of a combination of vitamin E, an antioxidant, and Eve Primrose in the management of painful diabetes mellitus (DM) neuropathy. MATERIALS AND METHODS: This was an interventional study that evaluated the efficacy and safety of a combination of vitamin E and Eve Primrose in the management of DM neuropathy. The study was conducted at the Diabetic Centre of the Lagos State University Teaching Hospital, Ikeja. Eighty individuals with type 2 DM who had painful neuropathy were recruited for this study, which took place for a duration of 1 year. The study subjects underwent clinical and biochemical assessment at baseline and were given vitamin E in a dose of 400 mg in combination with Eve Primrose in doses ranging 500-1000 mg/day. They were afterward assessed for relief of symptoms and possible untoward effects after 2 weeks and, thereafter, monthly for 3 months. The main outcome measure was amelioration of symptoms of neuropathy. RESULTS: The mean age and age range of the study subjects were 58.2 years and 37-70 years, respectively. A total of 70 patients (88%) of the study population reported relief from neuropathic pains. Clinical parameters were comparable between the responders and non-responders. One characteristic feature of the non-responders was that they all had vibration perception threshold of ≥25 mV, which was indicative of severe neuropathy. CONCLUSION: The combination of vitamin E and Eve Primrose is beneficial in the management of mild to moderate diabetic neuropathy. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4192992/ /pubmed/25364681 http://dx.doi.org/10.4103/2230-8210.140270 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ogbera, Anthonia Okeoghene Ezeobi, Emmanuel Unachukwu, Chioma Oshinaike, Olajumoke Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose |
title | Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose |
title_full | Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose |
title_fullStr | Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose |
title_full_unstemmed | Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose |
title_short | Treatment of diabetes mellitus-associated neuropathy with vitamin E and Eve primrose |
title_sort | treatment of diabetes mellitus-associated neuropathy with vitamin e and eve primrose |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192992/ https://www.ncbi.nlm.nih.gov/pubmed/25364681 http://dx.doi.org/10.4103/2230-8210.140270 |
work_keys_str_mv | AT ogberaanthoniaokeoghene treatmentofdiabetesmellitusassociatedneuropathywithvitamineandeveprimrose AT ezeobiemmanuel treatmentofdiabetesmellitusassociatedneuropathywithvitamineandeveprimrose AT unachukwuchioma treatmentofdiabetesmellitusassociatedneuropathywithvitamineandeveprimrose AT oshinaikeolajumoke treatmentofdiabetesmellitusassociatedneuropathywithvitamineandeveprimrose |